Cargando…
Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study
BACKGROUND: Hypernatremia is a major electrolyte disorder associated with death among critically ill patients. Glucocorticoid therapy may cause hypernatremia in refractory septic shock patients, but the association between glucocorticoid and intensive care unit (ICU)-acquired hypernatremia (IAH) rem...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506169/ https://www.ncbi.nlm.nih.gov/pubmed/32960424 http://dx.doi.org/10.1007/s10157-020-01967-9 |
_version_ | 1783584973797720064 |
---|---|
author | Imaizumi, Takahiro Nakatochi, Masahiro Fujita, Yoshiro Yamamoto, Rie Watanabe, Kennshi Maekawa, Michitaka Yamawaka, Taishi Katsuno, Takayuki Maruyama, Shoichi |
author_facet | Imaizumi, Takahiro Nakatochi, Masahiro Fujita, Yoshiro Yamamoto, Rie Watanabe, Kennshi Maekawa, Michitaka Yamawaka, Taishi Katsuno, Takayuki Maruyama, Shoichi |
author_sort | Imaizumi, Takahiro |
collection | PubMed |
description | BACKGROUND: Hypernatremia is a major electrolyte disorder associated with death among critically ill patients. Glucocorticoid therapy may cause hypernatremia in refractory septic shock patients, but the association between glucocorticoid and intensive care unit (ICU)-acquired hypernatremia (IAH) remains unclear. The aim of this study was to clarify whether glucocorticoid administration was associated with IAH. METHODS: This was a nested case–control study using data from an established cohort including 121 IAH cases identified from 1756 patients who were admitted to ICU in a tertiary care facility in Japan. We included patients who were admitted with a normal range of serum sodium concentrations (130–149 mEq/L) from January 1, 2013 to December 31, 2015 and remained in ICU for ≥ 2 days. Hypernatremia was defined as serum sodium concentration ≥ 150 mEq/L. Each case was matched to one control. RESULTS: Multivariable conditional logistic regression revealed high-dose glucocorticoid {odds ratio (OR), 4.15 [95% confidence interval (CI) 1.29–13.4]}, acute kidney injury (AKI) [OR, 2.72 (95% CI 1.31–5.62)], and osmotic diuretics [OR, 3.44 (95% CI 1.41–8.39)] to be significantly associated with IAH. The contents and amounts of fluid infusion were not significantly associated with IAH. There were also significant duration–response effects between duration of glucocorticoid use and IAH; however, pulse glucocorticoid administration was not associated with IAH. CONCLUSION: In this nested case–control study, we demonstrated a significant association between IAH and high-dose glucocorticoid with significant duration–response effects. Serum sodium concentrations should be monitored carefully in critically ill patients administered prolonged high-dose glucocorticoid. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10157-020-01967-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7506169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-75061692020-09-23 Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study Imaizumi, Takahiro Nakatochi, Masahiro Fujita, Yoshiro Yamamoto, Rie Watanabe, Kennshi Maekawa, Michitaka Yamawaka, Taishi Katsuno, Takayuki Maruyama, Shoichi Clin Exp Nephrol Original Article BACKGROUND: Hypernatremia is a major electrolyte disorder associated with death among critically ill patients. Glucocorticoid therapy may cause hypernatremia in refractory septic shock patients, but the association between glucocorticoid and intensive care unit (ICU)-acquired hypernatremia (IAH) remains unclear. The aim of this study was to clarify whether glucocorticoid administration was associated with IAH. METHODS: This was a nested case–control study using data from an established cohort including 121 IAH cases identified from 1756 patients who were admitted to ICU in a tertiary care facility in Japan. We included patients who were admitted with a normal range of serum sodium concentrations (130–149 mEq/L) from January 1, 2013 to December 31, 2015 and remained in ICU for ≥ 2 days. Hypernatremia was defined as serum sodium concentration ≥ 150 mEq/L. Each case was matched to one control. RESULTS: Multivariable conditional logistic regression revealed high-dose glucocorticoid {odds ratio (OR), 4.15 [95% confidence interval (CI) 1.29–13.4]}, acute kidney injury (AKI) [OR, 2.72 (95% CI 1.31–5.62)], and osmotic diuretics [OR, 3.44 (95% CI 1.41–8.39)] to be significantly associated with IAH. The contents and amounts of fluid infusion were not significantly associated with IAH. There were also significant duration–response effects between duration of glucocorticoid use and IAH; however, pulse glucocorticoid administration was not associated with IAH. CONCLUSION: In this nested case–control study, we demonstrated a significant association between IAH and high-dose glucocorticoid with significant duration–response effects. Serum sodium concentrations should be monitored carefully in critically ill patients administered prolonged high-dose glucocorticoid. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10157-020-01967-9) contains supplementary material, which is available to authorized users. Springer Singapore 2020-09-22 2021 /pmc/articles/PMC7506169/ /pubmed/32960424 http://dx.doi.org/10.1007/s10157-020-01967-9 Text en © Japanese Society of Nephrology 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Imaizumi, Takahiro Nakatochi, Masahiro Fujita, Yoshiro Yamamoto, Rie Watanabe, Kennshi Maekawa, Michitaka Yamawaka, Taishi Katsuno, Takayuki Maruyama, Shoichi Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study |
title | Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study |
title_full | Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study |
title_fullStr | Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study |
title_full_unstemmed | Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study |
title_short | Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study |
title_sort | glucocorticoid treatment is associated with icu-acquired hypernatremia: a nested case–control study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506169/ https://www.ncbi.nlm.nih.gov/pubmed/32960424 http://dx.doi.org/10.1007/s10157-020-01967-9 |
work_keys_str_mv | AT imaizumitakahiro glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy AT nakatochimasahiro glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy AT fujitayoshiro glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy AT yamamotorie glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy AT watanabekennshi glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy AT maekawamichitaka glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy AT yamawakataishi glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy AT katsunotakayuki glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy AT maruyamashoichi glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy |